Fritz Lai
Newcastle, NSW 2308, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction to: RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors.
Journal: Cell death & disease
Published: March 07, 2019
RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors.
Journal: Cell death & disease
Published: August 08, 2017
Oncogenic activation of MEK/ERK primes melanoma cells for adaptation to endoplasmic reticulum stress.
Journal: The Journal of investigative dermatology
Published: March 03, 2013
The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance.
Journal: Carcinogenesis
Published: October 23, 2012
Histone deacetylases (HDACs) as mediators of resistance to apoptosis in melanoma and as targets for combination therapy with selective BRAF inhibitors.
Journal: Advances in pharmacology (San Diego, Calif.)
Published: September 11, 2012
Evidence for upregulation of Bim and the splicing factor SRp55 in melanoma cells from patients treated with selective BRAF inhibitors.
Journal: Melanoma research
Published: April 21, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026